ADIAL PHARMACEUTICALS, INC. Quarterly Earnings Per Share, Basic in USD/shares from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Adial Pharmaceuticals, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from Q2 2021 to Q2 2024.
  • Adial Pharmaceuticals, Inc. Earnings Per Share, Basic for the quarter ending June 30, 2024 was -0.59 USD/shares, a 161% decline year-over-year.
  • Adial Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2023 was -3.6 USD/shares, a 71.7% increase from 2022.
  • Adial Pharmaceuticals, Inc. annual Earnings Per Share, Basic for 2022 was -12.7 USD/shares, a 1122% decline from 2021.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$1 -$2 -161% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q4 2023 -$4 -$3 +$2.33 +41.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$6 -$1 +$1.84 +60.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$8 $0.96 +$4.92 Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 -$13 $0 +$0.02 +15.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 -$13 -$6 Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$3 -$3 -1273% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$4 -$4 -1484% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-10-30
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.